We are live on
!
Find out more
AstraZeneca
AZN
AZN
546 hedge funds and large institutions have $19B invested in AstraZeneca in 2019 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 186 increasing their positions, 196 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more call options, than puts
Call options by funds: $134M | Put options by funds: $107M
2% less capital invested
Capital invested by funds: $19.3B → $19B (-$316M)
5% less repeat investments, than reductions
Existing positions increased: 186 | Existing positions reduced: 196
7% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 58
1.3% less ownership
Funds ownership: 18.83% → 17.53% (-1.3%)
2% less funds holding
Funds holding: 559 → 546 (-13)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Holders
546
Holders Change
-13
Holders Change %
-2.33%
% of All Funds
11.86%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
54
Increased
186
Reduced
196
Closed
58
Calls
$134M
Puts
$107M
Net Calls
+$26.6M
Net Calls Change
+$36.2M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$475M |
| 2 |
Jennison Associates
New York
|
-$375M |
| 3 |
Morgan Stanley
New York
|
-$196M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$121M |
| 5 |
YCMGA
York Capital Management Global Advisors
New York
|
-$57.9M |
